SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-24-092033
Filing Date
2024-04-10
Accepted
2024-04-10 17:10:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC14D9C d816914dsc14d9c.htm SC14D9C 19368
2 EX-99.1 d816914dex991.htm EX-99.1 25830
3 EX-99.2 d816914dex992.htm EX-99.2 26879
4 GRAPHIC g816914g70k24.jpg GRAPHIC 103477
5 GRAPHIC g816914g78f04.jpg GRAPHIC 6391
  Complete submission text file 0001193125-24-092033.txt   225732
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filed by) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-88896 | Film No.: 24836549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)